Clinical

The new Innovation in Behavioral Health (IBH) Model is designed to test for improving outcomes for adults with mental health and substance use disorder; patients with long COVID show prolonged activation of the immune system’s complement system after an acute infection; scientists now believe our bodies benefit most when our sleep is consistent, not just long.

This literature review investigated outcomes related to relapsed/refractory multiple myeloma (MM) among patients 65 years and older.

The researchers suggested that physicians consider age-relevant atopic dermatitis (AD) treatment preferences in discussions with patients and caregivers.

CMS has announced new federal rules that require health insurers to streamline requests to cover treatments; nearly 50,000 veterans used the emergency suicide prevention program launched by the Department of Veteran Affairs in 2023; the FDA recently authorized the first artificial intelligence (AI)-powered medical device to help doctors detect the most common forms of skin cancer.

Key opinion leaders share their final thoughts on advancing treatments of Dry Eye Disease.

A professional analysis of the potential cost-effective impact of emerging dry eye therapies on the health care system.

Asthma can be predicted using non-biological measurements from the age of 3 years, according to one study.

Physicians should be vigilant when managing patients with psoriasis and concurrent metabolic disorders, according to a new study.

Aside from semaglutide, alternate weight loss routes include other anti-obesity medications, chronic weight management programs, or obesity medicine specialists, said Ian Neeland, MD.

Incidence of colorectal cancer is expected to rise in both male and female patients aged 50 years and younger.

Families with workplace health insurance may have missed out on $125,000 in earnings over the past 3 decades due to rising premiums; so far, there have been about 600 drug price hikes in January; experts worry that minority and low-income people will not have easy access to zuranolone, the first FDA-approved postpartum depression pill.

Breastfeeding infants during the first 3 months can lower their risk of childhood obesity, regardless of the mother's body mass index before pregnancy.

Medical professionals explore CSCC and BCC treatment in high-risk, immunocompromised patients—specifically in the setting of organ transplantation.

Experts explore the socioeconomic impact of CSCC and BCC, and which late-stage patients will derive the greatest benefit from hedgehog inhibitors, immunotherapies, and other emerging treatments.

Shifting from an opt-in to an opt-out approach boosted palliative care consults from 16.6% of eligible patients to 43.9%, the investigators found.

In a systematic review and meta-analysis, real-time continuous glucose monitoring (CGM) demonstrated benefits in terms of time in range, hypoglycemia, and hyperglycemia among patients with type 1 diabetes (T1D).

Gabapentinoid use, namely gabapentin and pregabalin, was associated with increased risk for severe chronic obstructive pulmonary disease (COPD) exacerbation in patients with epilepsy, neuropathic pain, and other chronic pain.

Despite there being more patients undergoing bariatric surgery since the Affordable Care Act (ACA) was enacted in 2010, these surgeries had better postoperative outcomes.

An artificial intelligence (AI)-aided stethoscope provides reliable information on asthma exacerbations in children, especially those under 5 years, a study suggests.

Jeff McIntyre, MA, of the Global Liver Institute (GLI), discusses the importance of the health care community understanding non-alcoholic steatohepatitis (NASH) and how to mitigate its global impact.

Ian Neeland, MD, of University Hospitals Harrington Heart & Vascular Institute, talks about the uptick in patients at his practice seeking semaglutide for weight loss.

Merck’s pembrolizumab (Keytruda) gains expanded approval for advanced cervical cancer; delay of final rules banning menthol cigarettes and flavored cigars; high rates of diagnostic errors lead to harm and deaths, study finds.

Medical experts dissect critical strategies for monitoring for potential adverse events with bispecific antibodies in a comprehensive panel discussion.

Practical guidance for institutions navigating bispecific therapy integration without prior experience is provided.

The study's findings suggest that high baseline white blood cell count, particularly high neutrophil count, was associated with a higher incidence of long-term acute exacerbation of chronic obstructive pulmonary disease (COPD).